Molecular structure of Benazepril-d5, CAS Number: 1279200-03-1
Benazepril-d5 (CAS 1279200-03-1)
Alternate Names:
(3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic Acid; Lotensin
Application:
Benazepril-d5 is a deuterium labeled ACE inhibitor
CAS Number:
1279200-03-1
Molecular Weight:
429.52
Molecular Formula:
C24H23D5N2O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Labeled Benazepril, which is used as an antihypertensive.
Benazepril-d5 (CAS 1279200-03-1) References
- Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group. | Colfer, HT., et al. 1992. Am J Cardiol. 70: 354-8. PMID: 1632402
- Impact of Lotensin and Salviae on the changes of TGF-beta1 and its receptors in a rat model of chronic cyclosporine-induced nephropathy. | Peng, B., et al. 2006. Transplant Proc. 38: 2183-6. PMID: 16980037
- Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure. | Balfour, JA. and Goa, KL. 1991. Drugs. 42: 511-39. PMID: 1720384
- The pharmacokinetics of benazepril relative to other ACE inhibitors. | Gengo, FM. and Brady, E. 1991. Clin Cardiol. 14: IV44-50; discussion IV51-5. PMID: 1893642
- Antihypertensive and organ-protective effects of benazepril. | Barrios, V. and Escobar, C. 2010. Expert Rev Cardiovasc Ther. 8: 1653-71. PMID: 21108548
- Benazepril in dogs with asymptomatic mitral valve disease. | Brennan, M. and Stavisky, J. 2015. Vet Rec. 177: 392. PMID: 26475899
- IGF-1R Inhibitor Ameliorates Diabetic Nephropathy with Suppressed HMGN1/TLR4 Pathway. | Yu, J., et al. 2018. Endocr Metab Immune Disord Drug Targets. 18: 241-250. PMID: 29384065
- Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers. | Schaller, MD., et al. 1985. Eur J Clin Pharmacol. 28: 267-72. PMID: 2988972
- Decreased expression of transforming growth factor-β1 and α-smooth muscle actin contributes to the protection of lotensin against chronic renal failure in rats. | Xiao, Q., et al. 2018. Ren Fail. 40: 583-589. PMID: 30371125
- DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study. | Borgarelli, M., et al. 2020. J Vet Cardiol. 27: 34-53. PMID: 32032923
- Comparison of Irbesartan and Benazepril Hydrochloride on Urine Protein Reduction in Chronic Glomerulonephritis. | Liu, Z., et al. 2020. J Coll Physicians Surg Pak. 30: 1000-1001. PMID: 33036695
- Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST). | Coffman, M., et al. 2021. J Vet Intern Med. 35: 1673-1687. PMID: 34028078
- ACE inhibitors: review of four new agents. | Binder, SB. 1993. Am Fam Physician. 48: 851-7. PMID: 8213415
- Delayed onset of angioedema with angiotensin-converting enzyme inhibitors: case report and review of the literature. | O'Mara, NB. and O'Mara, EM. 1996. Pharmacotherapy. 16: 675-9. PMID: 8840375
- Angiotensin-Converting Enzyme Inhibitors | . 2012. Livertox: Clinical And Research Information On Drug-Induced Liver Injury.
Inhibitor of:
ACE.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Benazepril-d5, 1 mg | sc-217708 | 1 mg | $367.00 |